Compass Therapeutics 10-Q 2003 Q2 Quarterly report

Exhibit 99.2

CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Compex Technologies, Inc. (the “Company”) on Form 10-Q for the quarter ended December 31, 2002, as filed with Securities and Exchange Commission on the date hereof (the “Report”), I, Scott P. Youngstrom, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Scott P. Youngstrom

Scott P. Youngstrom
Chief Financial Officer
February 12, 2003

21